Intuitive Surgical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	10,065	8,352	7,124	6,222	5,710
Revenue Growth (YoY)	20.51%	17.24%	14.49%	8.97%	31.01%
Cost of Revenue	3,422	2,718	2,395	2,026	1,752
Gross Profit	6,642	5,634	4,730	4,196	3,959
Selling, General & Admin	2,385	2,140	1,964	1,712	1,467
Research & Development	1,312	1,145	998.8	879	671
Operating Expenses	3,697	3,285	2,963	2,591	2,138
Operating Income	2,946	2,349	1,767	1,605	1,821
Interest & Investment Income	380.9	327.6	195.8	78	80.8
Currency Exchange Gain (Loss)	-13	-2.7	-3.7	-27.3	-0.9
EBT Excluding Unusual Items	3,313	2,674	1,959	1,656	1,901
Gain (Loss) on Sale of Investments	-2	-	-	-21	-10.6
Legal Settlements	-	-	-	-28.1	-
Pretax Income	3,311	2,674	1,959	1,607	1,890
Income Tax Expense	434.8	336.3	141.6	262.4	162.2
Earnings From Continuing Operations	2,877	2,338	1,817	1,344	1,728
Minority Interest in Earnings	-20.6	-14.9	-19.3	-22.1	-23.5
Net Income	2,856	2,323	1,798	1,322	1,705
Net Income to Common	2,856	2,323	1,798	1,322	1,705
Net Income Growth	22.97%	29.18%	35.98%	-22.43%	60.72%
Shares Outstanding (Basic)	357	355	351	356	356
Shares Outstanding (Diluted)	363	362	357	362	366
Shares Change (YoY)	0.19%	1.29%	-1.27%	-1.04%	1.33%
EPS (Basic)	8.00	6.54	5.12	3.72	4.79
EPS (Diluted)	7.87	6.42	5.03	3.65	4.66
EPS Growth	22.59%	27.63%	37.81%	-21.67%	58.50%
Free Cash Flow	2,491	1,304	749.6	958.4	1,750
Free Cash Flow Per Share	6.87	3.60	2.10	2.65	4.78
Gross Margin	66.00%	67.46%	66.39%	67.44%	69.33%
Operating Margin	29.27%	28.12%	24.80%	25.80%	31.89%
Profit Margin	28.38%	27.81%	25.24%	21.25%	29.85%
Free Cash Flow Margin	24.75%	15.61%	10.52%	15.40%	30.65%
EBITDA	3,558	2,805	2,169	1,959	2,128
EBITDA Margin	35.35%	33.58%	30.45%	31.48%	37.27%
D&A For EBITDA	612.5	455.7	402.2	353.8	307.4
EBIT	2,946	2,349	1,767	1,605	1,821
EBIT Margin	29.27%	28.12%	24.80%	25.80%	31.89%
Effective Tax Rate	13.13%	12.58%	7.23%	16.33%	8.58%
Revenue as Reported	10,065	8,352	7,124	6,222	5,710

Updated Jan 22, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q